Europe Vitreoretinal Surgery Devices Market by Types, by End-Users – Analysis and Forecast to 2019

The European Vitreoretinal Market is estimated to grow at a CAGR of 13.5% from 2014-2019. Germany accounted for the maximum market share and is estimated to grow at a CAGR of 9.9%. France accounted for the second largest market share. Vitreoretinal market is divided into sub-types (Photocoagulation, Vitrectomy, and Illumination Devices), where the repair by photocoagulation segment has the highest market share and shows a comparatively higher growth rate among the other segments.
There have been many developments in the market, such as approvals received by the top players and collaborations to increase the technical efficiency of the procedures and deliver good results in the market. Abbott received U.S. Food and Drug Administration clearance for its iFS Advanced femtosecond laser used in corneal and cataract surgery. The product has helped to create bow-shaped or curved arcuate incisions during surgery. The approval strengthened AMO’s Femtosecond laser technology for ophthalmology and offered an advanced technique for cataract procedures.
The overall market growth has been positive and is continued to remain similar until 2019. The report has profiled the leading players of this market along with the developments (new product launches and partnerships, agreements, collaborations, and joint ventures) done by the companies over the past few years and strategies adopted by them to sustain and strengthen their position in the European vitreoretinal surgery devices market.
The key players in the European vitreoretinal surgery devices market are Abbott Laboratories (U.S.), Alcon, Inc. (Switzerland), Carl Zeiss Meditec AG (Germany), Nidek Co., Ltd. (U.S.) and many more.

Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends, and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape, usage patterns, emerging- and high-growth segments of the ophthalmology surgery devices market, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.
The report provides information on established companies as well as new entrants/smaller firms along with the market share. Also, the strategies adopted by the companies such as (market penetration, product development/innovation, market development, market diversification, and competitive assessment) have been covered in the report.
The report provides insights on the following pointers:
‧ Product Analysis and development: Detailed insights on upcoming technologies, research and development activities, and new product launches in the European vitreoretinal surgery devices market. Usage pattern/ penetration rate (in-depth trend analysis) of products (Segment wise) and purchasing data. Comprehensive coverage of Product approvals, Patent analysis, Pipeline products and Product recalls.
‧ Market Development: Comprehensive information about lucrative emerging markets. The report analyses the markets for the European vitreoretinal surgery devices across geographies, exploits new distribution channels, new clientele base and different pricing policies.
‧ Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments decisions in the European vitreoretinal surgery devices devices. Detailed description regarding the related and unrelated diversification pertaining to this market.
‧ Competitive Assessment: In-depth assessment of market shares, company share analysis of the key players forecast till 2019. To develop business strategies and manufacturing capabilities of leading players enhances the bottom line of the companies in the European vitreoretinal surgery devices market.
‧ Product/ Brand Perception Analysis: Comprehensive study of customers perception and behaviour through the inbuilt social connect tool (digital marketing language) checking the vitality and tonality of blogs.

TABLE OF CONTENTS

1 INTRODUCTION 9
1.1 OBJECTIVES OF THE STUDY 9
1.2 MARKET SEGMENTATION & COVERAGE 10
1.3 STAKEHOLDERS 10
2 RESEARCH METHODOLOGY 11
2.1 INTEGRATED ECOSYSTEM OF VITREORETINAL SURGERY DEVICES MARKET 12
2.1.1 TOP-DOWN APPROACH 13
2.1.2 BOTTOM-UP APPROACH 14
2.1.3 DEMAND SIDE APPROACH 15
2.1.4 MACRO INDICATOR-BASED APPROACH 16
2.2 ASSUMPTIONS 17
3 EXECUTIVE SUMMARY 18
4 MARKET OVERVIEW 19
4.1 INTRODUCTION 19
4.2 EUROPE VITREORETINAL SURGERY DEVICES : COMPARISON WITH PARENT MARKET 20
4.3 MARKET DRIVERS AND INHIBITORS 21
4.4 KEY MARKET DYNAMICS 22
4.5 DEMAND SIDE ANALYSIS 24
5 EUROPE VITREORETINAL SURGERY DEVICES MARKET, BY END-USER 26
5.1 INTRODUCTION 27
5.2 EUROPE VITREORETINAL SURGERY DEVICES MARKET IN PRIVATE EYE CLINICS,
BY GEOGRAPHY 28
5.3 EUROPE VITREORETINAL SURGERY DEVICES MARKET IN HOSPITALS, BY GEOGRAPHY 29
6 EUROPE VITREORETINAL SURGERY DEVICES MARKET, BY TYPE 30
6.1 INTRODUCTION 31
6.2 EUROPE: VITREORETINAL SURGERY DEVICES MARKET, TYPE COMPARISON WITH OPHTHALMOLOGY SURGERY DEVICES MARKET 32
6.3 EUROPE :PHOTOCOAGULATION VITREORETINAL SURGERY DEVICES MARKET,
BY GEOGRAPHY 33
6.4 EUROPE : VITRECTOMY VITREORETINAL SURGERY DEVICES MARKET, BY GEOGRAPHY 34
6.5 EUROPE : ILLUMINATION VITREORETINAL SURGERY DEVICES MARKET, BY GEOGRAPHY 35
7 EUROPE VITREORETINAL SURGERY DEVICES MARKET, BY GEOGRAPHY 36
7.1 INTRODUCTION 37
7.2 GERMANY : VITREORETINAL SURGERY DEVICES MARKET 38
7.2.1 GERMANY : VITREORETINAL SURGERY DEVICES MARKET, BY END-USERS 38
7.2.2 GERMANY : VITREORETINAL SURGERY DEVICES MARKET, BY TYPE 40
7.3 FRANCE : VITREORETINAL SURGERY DEVICES MARKET 42
7.3.1 FRANCE : VITREORETINAL SURGERY DEVICES MARKET, BY END-USERS 42
7.3.2 FRANCE : VITREORETINAL SURGERY DEVICES MARKET, BY TYPE 44
7.4 U.K. : VITREORETINAL SURGERY DEVICES MARKET 45
7.4.1 U.K.: VITREORETINAL SURGERY DEVICES MARKET, BY END-USERS 46
7.4.2 U.K.: VITREORETINAL SURGERY DEVICES MARKET, BY TYPE 47
7.5 ITALY : VITREORETINAL SURGERY DEVICES MARKET 49
7.5.1 ITALY : VITREORETINAL SURGERY DEVICES MARKET, BY END-USERS 49
7.5.2 ITALY : VITREORETINAL SURGERY DEVICES MARKET, BY TYPE 51
7.6 SPAIN : VITREORETINAL SURGERY DEVICES MARKET 52
7.6.1 SPAIN: VITREORETINAL SURGERY DEVICES MARKET, BY END-USERS 53
7.6.2 SPAIN : VITREORETINAL SURGERY DEVICES MARKET, BY TYPE 54
8 EUROPE VITREORETINAL SURGERY DEVICES MARKET: COMPETITIVE LANDSCAPE 56
8.1 EUROPE VITREORETINAL SURGERY DEVICES MARKET: COMPANY SHARE ANALYSIS 56
8.2 MERGERS & ACQUISITIONS 57
8.3 AGREEMENTS/PARTNERSHIPS/COLLABORATIONS 58
8.4 NEW TECHNOLOGY/PRODUCT DEVELOPMENT 59
9 EUROPE VITREORETINAL SURGERY DEVICES MARKET, BY COMPANY 60
(Overview, Financials, Products & Services, Strategy, and Developments)*
9.1 ABBOTT LABORATORIES 60
9.2 ALCON, INC. 63
9.3 ALLERGAN, INC. 65
9.4 BAUSH & LOMB, INC. 67
9.5 CARL ZEISS MEDITECH AG 69
9.6 ESSILOR INTERNATIONALS S.A. 72
9.7 NIDEK CO., LIMITED 74
9.8 TOPCON CORPORATION 77
*Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company
10 APPENDIX 79
10.1 CUSTOMIZATION OPTIONS 79
10.1.1 PRODUCT ANALYSIS 79
10.1.2 SURGEONS/PHYSICIANS PERCEPTION ANALYSIS 79
10.1.3 BRAND/PRODUCT PERCEPTION MATRIX 79
10.1.4 IMPACT ANALYSIS 79
10.1.5 PORTER’S FIVE FORCES ANALYSIS 79
10.2 RELATED REPORTS 80
10.3 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE 81
10.3.1 RT SNAPSHOTS 82